StockData

Niki BioSolutions, Inc. (NIKI) stock

NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2025, quý kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 4/30
$1.60+0.10 (+6.67%)

Close on Nov 18, 2026Market cap $13.03MP/E –Yield –

Niki BioSolutions gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2023 it was 2.4%, against 6.2% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 20232.4%−3.7
FY2022Dec 31, 20226.2%+0.9
FY2021Dec 31, 20215.3%–

More Niki BioSolutions figures

See a number that looks wrong?